1. DOP38 Upadacitinib Therapy Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy. (30th January 2023) Authors: Colombel, J F; Hisamatsu, T; Bresso, F; Thin, L; Parra, R; Ford, S; Remple, V; Lacerda, A P; Hecht, P; Mallick, M; Garrison, A; Regueiro, M Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P491 Efficacy and safety of upadacitinib for the treatment of fistulas and fissures in patients with Crohn's disease. (30th January 2023) Authors: Colombel, J F; Irving, P; Rieder, F; Panaccione, R; Schwartz, D; Hayashi, R; Zhu, X; Lacerda, A P; Dubcenco, E; Marced, E; Hecht, P; Feng, T; Berg, S; Reinisch, W Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i620 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗